Paving the way for patient-centricity in 2024
Brad Bailey is Senior Vice President and U.S. General Manager for Genmab, a global biotechnology company at the forefront of discovering, developing, and delivering …
BIO Member Think Tank
Get BIO members’ views on everything from health care to biofuels and the bioeconomy. The below articles are articles and opinion editorials written by executives at BIO member companies, an exclusive benefit of BIO membership.
Genentech Q&A: Improving MS treatment and clinical trial diversity
In October 2023, Genentech announced results from the first-ever clinical trial designed exclusively to enhance the knowledge base supporting the Black and Hispanic population …
Genentech Q&A: Improving MS treatment and clinical trial diversity Read More »
Novavax’s Choose to Protect campaign is dedicated to driving COVID vaccination
The U.S. is now entering its fourth season with COVID, and the new vaccination roll-out has begun, including the option of the highly anticipated …
Novavax’s Choose to Protect campaign is dedicated to driving COVID vaccination Read More »
Tackling health equity requires sustained, comprehensive, and collaborative interventions
Amgen Inc., an Advocate level sponsor of the 2023 BIO Patient & Health Advocacy Summit, provided their approval to share this previously published article …
Turning insights into action: building a U.S. health system that delivers for all women
Dr. Mary-Ann Etiebet, Associate Vice President, Health Equity, Merck, has more than two decades of experience working across the public and private sectors to …
Turning insights into action: building a U.S. health system that delivers for all women Read More »
BIO’s Emerging Start-Up Stadium winner: Paradox Immunotherapeutics
Within the challenging field of protein misfolding research, there is a company with a unique and competitive edge that is turning heads and making …
BIO’s Emerging Start-Up Stadium winner: Paradox Immunotherapeutics Read More »
BIO’s Seed-Stage Start-Up Stadium winner: PriZm Therapeutics
Out of the University of Miami, the industry’s first investigator-initiated emergency trial treating a pregnant mother has been authorized by the U.S. Food and …
BIO’s Seed-Stage Start-Up Stadium winner: PriZm Therapeutics Read More »
Kintara Q&A: novel treatments for aggressive cancers
Kintara Therapeutics, Biotechnology Innovation Organization (BIO) member, is an innovative, patient-centered biotech company that is working to change the game when it comes to …
Kintara Q&A: novel treatments for aggressive cancers Read More »
What you need to know about the upcoming flu season
September is a perfect time to schedule your flu vaccine– as well as COVID and, if you’re eligible, the new RSV vaccines. And with …
What you need to know about the upcoming flu season Read More »
How Predictive Oncology is using science, engineering, and AI to create more effective cancer treatments
A diagnosis of cancer can be overwhelming, but treatment doesn’t have to be. What if science, engineering, and machine learning were to collaborate and …